Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Teodora Festini | Researchclopedia

Back to researchers

Teodora Festini

Leo Pharma (Denmark)

9

Works

4

Citations

1

h-index

0

i10-index

Research Topics

Dermatology and Skin Diseases Psoriasis: Treatment and Pathogenesis Food Allergy and Anaphylaxis Research

Affiliations

Leo Pharma (Australia)2024–2024

Leo Pharma (Denmark)2025–2026

Top Works

Real-world Effectiveness of Tralokinumab in Adults with Atopic Dermatitis: Interim Data on Improvements in Patients with Head and Neck Atopic Dermatitis after up to 9 Months of Treatment in the TRACE Study

April W. Armstrong,Ahmed Ameen,et al.

20253 citations

Allergic Rhinitis and Sensitization

Urticaria and Related Conditions

Real-world Effectiveness of Tralokinumab in Adults with Atopic Dermatitis on the Genitals: Interim Data on Improvements in Physician-Assessed Disease Severity and Patient-Reported Outcomes in up to 3 Months of Treatment in the TRACE Study

E. Serra‐Baldrich,April W Armstrong,et al.

20251 citations

Safety and Adverse Events of Special Interest in 825 Adults With Atopic Dermatitis Receiving Up to 12 Months of Tralokinumab Treatment in a Real-World Setting

Cory Rubin,Abel Jarell,et al.

20260 citations

Real-world Effectiveness of Tralokinumab in Adults with Atopic Dermatitis: Interim Data on Improvements in Patients with Atopic Dermatitis with Hands and Feet Involvement after up to 9 Months of Treatment in the TRACE Study

Diamant Thaçi,Pierre André Becherel,et al.

20250 citations

Real-World Safety and Effectiveness of Up to 12 Months of Tralokinumab Treatment in Adults With Atopic Dermatitis Who Discontinued Dupilumab Due to Conjunctivitis

April Armstrong,Cory Rubin,et al.

20260 citations

Anchored Matching-Adjusted Indirect Comparison of the Long-Term Maintenance of Efficacy of Tralokinumab and Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis

Matthias Augustin,April W. Armstrong,et al.

20250 citations

Efficacité en vie réelle du tralokinumab chez les adultes atteints de dermatite atopique : résultats intermédiaires sur l’amélioration de la sévérité de la maladie évaluée par le médecin après un suivi allant jusqu’à 9 mois dans l’étude TRACE

F. Skowron,E. Pezzolo,et al.

20240 citations

Tralokinumab versus Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis with Hand Involvement: a Matching-Adjusted Indirect Comparison

April Armstrong,Leon Kircik,et al.

20260 citations

Real-World Effectiveness of Up to 12-Month Tralokinumab Treatment in Adults With Atopic Dermatitis Who Previously Discontinued Dupilumab or Janus Kinase Inhibitors

April Armstrong,Adrian Rodriguez,et al.

20260 citations